Vitagnus effect on premenstrual symptoms

Phase 3

• Conditions: Premenstrual Syndrome.; Unspecified condition associated with female genital organs and menstrual cycle

• Registration Number: IRCT2014102219632N1
• Lead Sponsor: Ahvaz University Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

students with premenstrual syndrome with regular menstrual cycle. exclusion criteria: Psychotherapy with pregnancy or breastfeeding; use of hormones; stress in the recent quarter such as marriage or the death of someone close surgery; patients taking certain medications such as dopamine antagonists used

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of the symptoms of premenstrual syndrome. Timepoint: one? two Three months after intervention. Method of measurement: Recorded daily symptoms of PMS.

Secondary Outcome Measures

Name	Time	Method
Side effects include itching, dizziness, stomach pain, diarrhea. Timepoint: Two weeks until 1 mounth. Method of measurement: Phone calls and monthly views.